The present invention concerns the synthesis of new analogs of angelicins, pyrrolo[3,2-h]quinoline, for the treatment of pathologie having hyperproliferative character including those having neoplastic nature. The treatment is based on the combined action of pyrrolo[3,2-h]quinolines and UV-A light, through a clinical approach defined as PUVA (psoralen-UVA light). The most important feature of these compounds is that they exert their remarkable phototoxicity without any DNA damage, which is the main origin of the side effects of the PUVA therapy
Dall'Acqua, F., Cirrincione, G., Barraja, P., Salvador, A. (2012)Photochemotherapeutic heterocyclic agents having antiproliferative and antineoplastic activity. . Brevetto No. US2012/0129884.
Photochemotherapeutic heterocyclic agents having antiproliferative and antineoplastic activity
CIRRINCIONE, Girolamo;BARRAJA, Paola;
2012-01-01
Abstract
The present invention concerns the synthesis of new analogs of angelicins, pyrrolo[3,2-h]quinoline, for the treatment of pathologie having hyperproliferative character including those having neoplastic nature. The treatment is based on the combined action of pyrrolo[3,2-h]quinolines and UV-A light, through a clinical approach defined as PUVA (psoralen-UVA light). The most important feature of these compounds is that they exert their remarkable phototoxicity without any DNA damage, which is the main origin of the side effects of the PUVA therapy
| File | Dimensione | Formato | |
|---|---|---|---|
|
US2012129884A1.pdf
Solo gestori archvio
Descrizione: international patent
Dimensione
1.01 MB
Formato
Adobe PDF
|
1.01 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
